Full Text View
Tabular View
No Study Results Posted
Related Studies
Characterization of Macroprolactinemia
This study has been completed.
First Received: February 15, 2007   No Changes Posted
Sponsored by: Kansai Medical University
Information provided by: Kansai Medical University
ClinicalTrials.gov Identifier: NCT00436111
  Purpose

The purpose of this study is to clarify the nature of macroprolactin which has recently been highlighted because of the high prevalence and a diagnostic pitfall of hyperprolactinemia. The results of this study are beneficial for the patients to whom unnecessary medications and unnecessary radiological examinations have been performed. We used the remained serum samples taken for routine prolactin determination during the past several years. Since the blood was basically taken to examine the causes of hyperprolactinemia and only remained serum samples were used for this study, the Ethics Committee of Kobe City General Hospital judged that it was not required to obtain approval number.


Condition
Hyperprolactinemia

U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective Study

Further study details as provided by Kansai Medical University:

Study Start Date: January 2005
Estimated Study Completion Date: December 2006
  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria: - Clinical diagnosis of hyperprolactinemia

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00436111

Locations
Japan
Kansai Medical University
Osaka, Japan, 570-8506
Sponsors and Collaborators
Kansai Medical University
Investigators
Study Chair: Naoki Hattori, M.D., Ph.D. Department of Pharmacology, Kansai Medical University
  More Information

Publications:
Study ID Numbers: KK-2007-1
Study First Received: February 15, 2007
Last Updated: February 15, 2007
ClinicalTrials.gov Identifier: NCT00436111     History of Changes
Health Authority: Japan: Ministry of Education, Culture, Sports, Science and Technology

Keywords provided by Kansai Medical University:
hyperprolactinemia
autoantibody

Study placed in the following topic categories:
Hypothalamic Diseases
Autoantibodies
Pituitary Diseases
Galactorrhoea-Hyperprolactinaemia
Endocrine System Diseases
Central Nervous System Diseases
Hyperprolactinemia
Endocrinopathy
Brain Diseases

Additional relevant MeSH terms:
Hypothalamic Diseases
Hyperpituitarism
Pituitary Diseases
Nervous System Diseases
Endocrine System Diseases
Central Nervous System Diseases
Hyperprolactinemia
Brain Diseases

ClinicalTrials.gov processed this record on May 07, 2009